{"disease":{"id":"hyperlipoproteinemias","name":"hyperlipoproteinemias"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05425745","title":"Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":354,"lead_sponsor_name":"NewAmsterdam Pharma","has_results":true},{"nct_id":"NCT04516291","title":"A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":286,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06163443","title":"Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms.","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"S.LAB (SOLOWAYS)","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}